BIOTECH STOCK INVESTING

Covering Biotech Stocks In The Following Areas'Drug Stocks' Gene Therapy' Stem Cells' DNA' Bio Metrics' Antibiotics' Vaccines' Cancer Drugs' Immune Therapy Drugs. Genetic Diseases' Nutrition Products. Nutraceuticals'. Some Of The Companies Covered Celgene'Gilead'Biogen'Vertex'Amgen'Abbvie'Regeneron'Alexion'Exelixis'Viking Therapeutics'Sarepta'Therapeutics'Sage Therapeutics'Incyte Corporation'Sparks Therapeutics'Puma Biotechnology'Neurocrine Bioscience'Astrazeneca'Celldex Therapeutics''

Thursday, August 29, 2019

U.S. Cannabis Market Is Booming, Curaleaf Chairman Says

Posted by jim moylan at 12:34 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Thursday, August 22, 2019

Tilray CEO Sees Canada Profit in the 'Next Quarter or Two'

Posted by jim moylan at 1:02 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Wednesday, August 14, 2019

Cannabis company Tilray beats revenue expectations but reports adjusted ...

Posted by jim moylan at 1:28 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Thursday, April 4, 2019

Buy Biogen on the dip? What about AMC on the streaming wars? The viewers...

Posted by jim moylan at 11:28 AM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Saturday, March 30, 2019

Albert Technologies reports near three-fold increase in 2018 revenues

Posted by jim moylan at 12:03 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Nuformix Plc kicks off clinical trial for its chemo side effect drug

Posted by jim moylan at 12:01 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

CytoDyn more than doubles recovery rate in its monotherapy HIV trial

Posted by jim moylan at 11:09 AM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Older Posts Home
Subscribe to: Comments (Atom)

Search This Blog

Followers

About Me

jim moylan
View my complete profile

Blog Archive

  • ▼  2019 (39)
    • ▼  August (3)
      • U.S. Cannabis Market Is Booming, Curaleaf Chairman...
      • Tilray CEO Sees Canada Profit in the 'Next Quarter...
      • Cannabis company Tilray beats revenue expectations...
    • ►  April (1)
    • ►  March (35)

Biotech Stock Investing

Simple theme. Powered by Blogger.